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Abstract
 .The ribosome inactivating plant proteins RIPs ricin and viscumin but not Ricinus communis agglutinin are able induce
vesicle–vesicle fusion. A model is suggested in which the toxicity of the RIPs is partially determined by their fusogenicity.
Herein, fusion is hypothesized to allow the RIPs to leak across endocytic vesicles to approve their access to cytoplasmic
ribosomes. q 1998 Elsevier Science B.V.
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The lectins ricin and viscumin from Ricinus com-
munis and Viscum album are known to inactivate
ribosomes. These proteins, which are among the most
w xpotently toxic compounds 1 can be selectively tar-
geted to specific cell types, such as cancer cells, by
w xlinking them to antibodies 2 . Their binding to cell
w xsurface receptors is followed by endocytosis 3 . It
has been shown that the subsequent delivery into the
cytosol across the membrane of an intracellular com-
w xpartment not only requires ATP 4 and membrane
w xproteins 5 but also depends on the retrograde trans-
port from the Golgi complex to the endoplasmic
 . w xreticulum ER 6 . The A-chain of these het-
erodimeric proteins is catalytically active whereas the
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B-chain binds oligosaccharide moieties. The concen-
trations required for 50% inhibition of cell-free pro-
tein synthesis in rabbit reticulocyte assay were esti-
w x w xmated to be 1.5 7 , 5.5 and 12 ngrml 8 for the
 .A-chains of ricin, R. communis agglutinin RCA and
viscumin, respectively. RCA is 2000-fold less toxic
than ricin when injected intraperitoneally into mice
w x w x9 whereas viscumin is as effective as ricin 10 . The
difference in cytotoxicity observed with different
lectins does not simply reflect the difference in bio-
w xlogical activity of the respective A-chains 7 . Rather,
it appears to be due to differences in the protein–lipid
interactions which in turn are crucial for the delivery
w xof the A-chains into the cytosol of target cells 7 .
Along with the A-chain of ricin other lectins,
w x w xnamely concavalin A 11 and annexin V 12 were
reported to induce membrane fusion. In turn, the
fusion event is known as an expedient means of
w xaccomplishing the passage into the cytoplasm 13 .
Therefore, we have undertaken a comparative analy-
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 98 00024-8
( )P. Pohl et al.rBiochimica et Biophysica Acta 1371 1998 11–1612
sis of the fusion capabilities of ricin, viscumin and
RCA in a model system where small unilamellar
vesicles were fused with planar bilayer membranes
 .BLM .
Ricin and RCA were purified from R. communis
w xseeds as described earlier 14 . Viscumin was isolated
w xfrom V. album 15 . Different lectin isoforms were
separated on a FPLC chromatograph Pharmacia,
.  .Sweden using Mono S HR column 5=5 with a
 .linear NaCl gradient 0–500 mM in 15 mM citric
buffer, pH 4.2.
Protein-free liposomes containing nystatin were
w xprepared as described by Woodbury and Miller 16 .
Around 2 mg of a lipid mixture were dissolved in 0.2
ml chloroform to which 10 ml of nystatin stock
 .solution 50 mg had been added. The lipids used
 .were: 45 mol% phosphatidyl-ethanolamine PE ; 9
 .mol% phosphatidyl-choline PC ; 18 mol% phos-
 . phatidyl-serine PS all from Avanti Polar Lipids,
.Alabaster, Alabama ; 18 mol% ergosterol and 10
mol% monosialoganglioside GM1; both Sigma,
.Dreisenhofen, Germany . After evaporating 0.5 ml of
a buffer solution 150 mM NaCl, 10 mM HEPES and
.10 mM MES, pH 7.5 were given to the dry lipid
film. The suspension was sonicated until its turbidity
became minimal.
w xBLM were formed by a conventional method 17
in a hole, 0.6 mm in diameter, of a diaphragm
dividing a Teflon-chamber. The membrane forming
solutions contained 14 mg bacterial PE and 6 mg
 .diphytanoyl-PC Avanti Polar Lipids per milliliter
solvent. The latter was a mixture of n-decane, chloro-
form and methanol 7:2:1 by volume, all Merck,
.Darmstadt, Germany . The membrane was sur-
 .  .  .Fig. 1. The effect of ricin A , viscumin B , and R. communis agglutinin C on the liposome fusion with a planar lipid membrane at pH
7.5 and after a subsequent acidification to pH 5.2. Spikes in the current across ergosterol and GM1 free bilayers appeared after fusion
with GM1 and nystatin containing liposomes. Both the vesicles and the proteins were added to the hypertonic side of the membrane. The
 .solution was buffered with 10 mM HEPES and 10 mM MES. A A 750 to 150 mM NaCl transmembrane gradient was established. Lipid
 .and ricin concentrations were 53 and 54 mgrml, respectively. B NaCl gradient was 650r350 mM. Lipid and viscumin concentrations
 .  .were 54 and 27 mgrml. C NaCl gradient was 600r150 mM. Lipid and RCA concentrations: 80 and 26 mgrml. D Inhibitory effect of
galactose on the liposome fusion. NaCl gradient was 550r150 mM. Lipid and viscumin concentrations: 135 and 27 mgrml, respectively.
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rounded by the buffer solution used for liposome
preparation. The solution was agitated by magnetic
bars.
The vesicles were added to the cis side of the
BLM. Their reliable and non-selective fusion to the
planar membrane was achieved due to an increase of
w xthe cis salt concentration to 450–650 mM 16 . The
fusion of every single vesicle with the BLM was
detected as a sudden jump in the transmembrane
current induced by the simultaneous insertion of many
nystatin channels from the ergosterol containing lipo-
w xsome 16 . The increase in conductance was transient
 .first trace in Fig. 1, panel A , i.e., it decayed back to
baseline before the next fusion event because ergo-
sterol, required for the integrity of the nystatin pore,
diffuses away into the sterol-free planar bilayer after
liposome fusion. The current across the BLM was
monitored via a picoamperemeter model 428, Keith-
.ley Instruments, Cleveland, OH connected to a x–t-
recorder. Both the stirring rate and the osmotic gradi-
ent were varied to achieve nearly the same fusion rate
in all experiments. For every single membrane the
average spike amplitude and the average time interval
between two neighbouring spikes were measured be-
 .  .fore U and t and after U and t protein addi-1 1 2 2
tion to the cis side of the BLM. The experimental
results achieved with different membranes were com-
pared in terms of the ratios R and R :A f
R sU rU , R s t rt 1 .A 2 1 f 1 2
The comparatively low variation of these parameters
allowed an interpretation of the results. Furthermore,
 .each experiment from 20 to 40 spikes was carried
out at least six times to get statistically significant
results.
After the addition of ricin to the cis side of the
 .membrane Fig. 1, panel A the spike amplitude
 .increased two-fold R s2.2"0.4 whereas the fre-A
quency did not change. The agglutinin induced oppo-
site effects. It increased the fusion rate R s2.0"f
. 0.5 but not the amplitude of the fusion spikes Fig.
.1, panel C . Only viscumin was able to affect both
 .parameters R s1.8"0.4, R s2.2"0.4 . Mostf A
pronounced was the effect of viscumin at acidic pH
 . Fig. 1, panel B . The fusion rate observed R s8.2f
."1.1 was at least four times the fusion rate induced
by acidification alone or by a pH drop in the presence
 .  .of ricin Fig. 1, panel A or RCA Fig. 1, panel B . In
the absence of the lectins, the modest pH sensitivity
 .of the liposome fusion rate R s1.8"0.6 may bef
contributed to the high amount of ethanolamines
w xpresent in the model membranes 13 . Galactose com-
 .petitive to the monosialoganglioside GM1 receptor
molecules incorporated into the liposomes inhibited
the fusion modulating effect of viscumin both at pH
 .  .7.5 Fig. 1, panel D and at pH 5.2 Fig. 1, panel B .
 .Each fusion spike Fig. 1 represents the fusion of
a single liposome carrying a package of preformed
w xnystatin channels 16 . There are two plausible expla-
nations for the two-fold increase of the fusion spikes
observed after the addition of both ricin and vis-
cumin. The first is that lectin binding to GM1 con-
taining liposomes resulted in a slower dissolution of
the nystatin–ergosterol complexes which led to larger
fusion spikes. This seems not to be the case because a
prolonged decay time per picoampere has not been
observed for the fusion spikes after the addition of
 .the ribosome inactivating plant proteins RIPs . The
second explanation is that RIP-induced vesicle–
vesicle fusion resulted in larger liposomes, which in
turn gave rise to larger fusion pulses. Because the
BLM conductance is raised in a single step, it is
excluded that aggregates of vesicles are responsible
for the effect. To support this assumption experimen-
tally, two populations of liposomes were prepared by
extrusion through 100 nm and 400 nm pore filters
w x18 using the small-volume apparatus LiposoFast
 .Avestin, Ottawa, Canada . Upon fusion with the
planar bilayer the average fusion spike for the smaller
vesicles was 2.0"0.5 pA whereas the large vesicles
 .elicited spikes of 6.6"2.1 pA Fig. 2 . Conse-
quently, the enlarged amplitude of the fusion spike
observed after the addition of viscumin and ricin
 .Fig. 1 reflects the fusion the BLM with large vesi-
cles that are originated by vesicle–vesicle fusion.
No channel activity could be contributed to sources
other than nystatin in any of the experiments carried
out with the lectins. Current fluctuations were ob-
served only in the presence of nystatin. Furthermore,
they were detectable only in the presence of a transbi-
layer osmotic gradient. Under the conditions of os-
motic equilibrium the RIPs did not induce fusion
between vesicles and the BLM.
If GM1 was not included into liposome mem-
branes neither the fusion rate nor the amplitude of the
spikes was altered by the lectins under investigation.
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Fig. 2. Fusion of GM1 containing liposomes prepared by extru-
 .sion of multilamellar vesicles through filters of 100 nm A and
 .400 nm B pore diameter with an ergosterol and GM1 free
planar bilayer. A NaCl gradient of 650 mM cis to 150 mM trans
was established. Some 65 mgrml liposomes were given to the
cis side of the planar membrane.
Interestingly, under these conditions it made no dif-
ference if GM1 was incorporated into the BLM or if
it were not. Addition of the glycolipid receptor to
both the planar and vesicular membranes revealed in
 .an enhanced lectin induced fusion rate Fig. 3B
similar to the one shown in Fig. 1A. Subsequent
acidification, however, was followed by multiple fu-
sions events even in the absence of the proteins Fig.
.3A . Accordingly, the lipid composition used in the
experiments shown in Fig. 1 is the only one suitable
for the investigation of lectin mediated fusion. Other
modifications, e.g., lowering of the PE content or an
enrichment with charged PS abolished membrane
fusion. From the above experiments it was concluded
that in an appropriate lipid environment ricin and
viscumin act as fusogens. Assuming that the lectins
exhibit the same capability under in vivo conditions
also, it may be suggested that fusion represents a
pathway for delivering the RIPs into the cytosol.
Therefore, it is required that during the fusion process
the integrity of the membrane of the intracellular
compartment encapsulating the RIPs is breached and
leakage or lysis takes place. Then the proteins may
enter the cytosol and reach their target, i.e., inhibit
ribosomal protein syntheses. This hypotheses is sup-
ported by the observation that the non-fusogenic RCA
is 2000-fold less toxic than the fusogens, ricin and
w xviscumin 10 , when injected intraperitoneally into
w xmice 9 .
Earlier ricin was reported to be incapable to fuse
model membranes made from fully saturated lipids
w xwith PC headgroups 19 . This failure may be origi-
 .nated by the absence of a lectin receptor GM1 and
the lipid dependence of the fusion event. Because
w xunsaturation is known to promote fusion 20 , the
liposomes used in the present study were made from
Fig. 3. The addition of GM1 to both vesicular and planar
 .membranes caused fusion events at pH 5.2 A that are not
distinguishable from those obtained in the presence of viscumin
 .under the same conditions B . A fusion stimulating effect of the
 .protein was observed at pH 7.4 B . A NaCl gradient of 450 mM
cis to 150 mM trans was established. 27 mgrml liposomes and
27 mgrml viscumin were given to the cis side of the planar
membrane.
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lipids that were at least to 50% unsaturated. Fusion
was further facilitated by incorporation of lipids with
PE headgroups. The displacement of interfacial water
w xby proteins is thereby eased 21 . While viscumin and
 .ricin were shown to act as fusogens Fig. 1 RCA
induced an increase in the frequency of fusion of
 .small vesicles with the BLM Fig. 1 only. RCA
should therefore be classified as a non-fusogenic
protein capable of modulating fusion between artifi-
cial membranes after modifying intramembrane con-
tact. This conclusion is in perfect agreement with the
observation that it decreases the threshold Ca2q-con-
w xcentration required for fusion 22 .
In general, fusion of purely lipid bilayers and
biological fusion are described to be lipid dependent
w x20 . Alterations in the cytotoxicity of both ricin and
viscumin observed after perturbations in Golgi func-
w xtions 23 are accompanied by a depletion of lipids
species required for fusion because the anterograde
membrane transport is inhibited. Consequently, the
lipid dependence of fusion provides an explanation
for the inhibition of ricin cytotoxicity by brefeldin A
 .BFA . The latter dramatically disrupts the structure
of the Golgi apparatus causing Golgi content and
w xmembrane to redistribute to the ER 24 . Commonly
an alternative explanation is given. The A-chain is
believed to translocate into the cytosol from the ER
after having been transported from the Golgi-com-
w xplex 25 . Although, recently experimental evidence
in favour of retrograde lectin transport was obtained
with mutant ricin, the existence of alternative path-
w xways can not be ruled out 26 . Moreover, the intoxi-
cation of cell lines that have an aberrant Golgi com-
w xplex 27,28 and the death of brefeldin A treated cells
induced by immunotoxins containing ricin A-chain
w x29 conflict with the suggested entry of the A-chain
from the ER but not with the fusion hypothesis. Here,
the intracellular compartment from which the protein
is delivered from depends on the capability of the
protein to function as a fusogen.
Further support for the hypotheses of fusion medi-
ated protein delivery comes from the observation that
after binding to cell surface glycoproteins with sig-
nalling potency, b-galactoside-specific lectins induce
changes in the level of phospholipids and inositol
w xphosphates 30 that are known to promote fusion.
Namely, diacylglycerol activation dramatically alters
w xthe kinetics of liposome fusion 31 .
With respect to the role of lipids in protein medi-
w xated fusion 20 we have shown that not only the
subchains of ricin and viscumin are able to aggregate
w x w x32,33 or fuse 19 lipid vesicles but the holotoxins
as well. The fusogenicity of the RIPs is hypothesized
allow their access to cytoplasmic ribosomes after
leakage across endocytic vesicles. The differences
found in their fusion capability in vitro might be
relevant for a therapeutic utilization of these proteins
w x w xin the treatment of cancer 34 , autoimmune 35 and
w xgraft-versus-host diseases 36 .
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